Buscar
Results for 'forms'
Clear-
Name-Brand Medication vs. Generic: What's the Difference?
Most prescriptions meds are available in generic form. Find out the similarities and differences between the two and how to determine whether a generic is right for you. Approximately 80 percent of prescriptions sold today are generics. If you’re taking a prescription medication, chances are it’s a generic form of the brand-name drug. But are you getting the same quality in a generic medication? Do generics measure up? The answer in most cases is yes — generics, just like branded products, are regulated by the Food and Drug Administration. “To have a generic product approved by the FDA, the generic manufacturer must prove that its product is bioequivalent to the branded product,” explains Adam Porath, PharmD, BCPS AQ-Cardiology, BCACP and Vice President of Pharmacy Services. Basically, it has to function the same. “Generic products are extremely well tolerated and will provide the same results as using a branded product,” Porath says. Here’s how generics are the same as name-brand prescriptions: Generic products contain the same active ingredients. They produce the same desired clinical effect and accompanying side effects. Generics come in the same form as their branded counterparts: pill, liquid or inhaler, for example. Release into the bloodstream matches the name brand in timing and strength. Here’s how they differ: Generics generally cost less. Federal law requires generics have different names and look different: shape, size, markings and color. Generics contain different inactive ingredients, like binders, fillers and artificial colors. Different side effects with generics can usually be attributed to these additions. Why do generics cost less? When pharmaceutical companies develop a new drug, they are paying for research, development, clinical studies, marketing — in some cases it can cost more than $800 million and take 10 to 15 years to develop a new drug. “The manufacturers of branded medication products have to recoup their research and development costs,” Porath says. So companies are granted a limited patent to sell their drug without the competition of generic counterparts. “When patent exclusivity ends, the market is open for any generic manufacturer to make a competing product with FDA approval.” Without the same startup costs, companies can sell generics at 80 to 85 percent less. And because more than one company can produce the same generics, competition drives prices even lower.
Read More About Name-Brand Medication vs. Generic: What's the Difference?
-
¿Qué es el Healthy Nevada Project?
The Healthy Nevada Project (HNP) is one of the most visible genomic studies in the United States, and guess what? Renown Health powers it! The Healthy Nevada Project (HNP) aligns with Renown's goal to do the best for our patients. The genomic study is at no-cost for Nevadans and gives participants insight into different genetic traits, including results on three prevalent and serious health conditions known as CDC Tier 1 conditions. CDC Tier 1 Conditions Include: Hereditary Breast and Ovarian Cancer Syndrome (HBOC) Lynch Syndrome Familial Hypercholesterolemia (FH) Not only does HNP give participants insights into their genetic background, but it also facilitates Renown's ability to study population health. Research lays the foundation for the future of medicine, and Renown's HNP is on the cutting edge of genetic research. We do this by providing skilled researchers access to studies for the diseases that currently have limited treatment, including nonalcoholic steatohepatitis liver disease or NASH. For example, the observational NASH study helps researchers understand genetic links to the disease. Make an Appointment to Get Screened If you haven't already, join the over 55,000 HNP participants and make an appointment to have yourself screened. You can schedule a screening appointment through MyChart. Click “Schedule an Appointment" and select Research Appointment - Genetic Screening. Prior to your appointment, please complete e-Check-in and complete your consent form.
-
Reno Home to "Great Psychiatry and Mental Health Program;" Renown and UNR School of Medicine Named to Becker's National List
Becker’s list of Hospitals and Health Systems with Great Psychiatry and Mental Health Programs for 2023 has been published, recognizing professional healthcare leaders across the country. Renown Health and the University of Nevada, Reno School of Medicine have been recognized among the top programs in the United States. This acknowledgement reflects a commitment from a dedicated team of experienced local professionals providing comprehensive mental health services and advancing the field of psychiatry. In their announcement, Becker’s highlighted that, “In 2018, a $6 million donation (by the Stacie Mathewson Foundation), funded the creation of the Stacie Mathewson Behavioral Health & Addiction Institute at Renown Health. The institute was formed to address increased prescription drug-related mortality rates and suicide rates in northern Nevada. The department is now fully integrated with University of Nevada School of Medicine's psychiatry residency, child and adolescent psychiatry fellowship programs, and behavioral sciences and clinical psychiatry medical student training. The curriculum emphasizes the value of psychotherapy, psychopharmacology, and interventional psychiatry methods, along with primary care team integration.” Becker’s editors noted that, “Innovative public and private partnerships with the state include the SOAR early intervention treatment program for those experiencing their first episode of psychosis. A 24-hour crisis stabilization center will open in 2024 for adults with mental health or substance use issues. The Connect Washoe County mental health collaborative, part of the hospital’s community benefit program, hosts the Youth Mental Health Summit, with a number of interventions resulting in reduced use of street and prescription drugs, lower hospitalization rates due to opioid overdose, and fewer cases of intentional suicide mortality in youth.” “We are honored to be recognized as one of the top psychiatry and mental health programs in the U.S. This achievement reflects the dedication of our integrated team and our unwavering commitment to enhancing the lives of individuals and families affected by mental health challenges. We will continue to strive for excellence and address the diverse needs of individuals struggling with behavioral health issues, said Takesha Cooper, MD, Department Chair of Psychiatry and Behavioral Sciences. “Our team comprises skilled psychiatrists, psychologists, therapists and support staff who collaborate to provide holistic and integrated care for our patients. As the region’s only not-for-profit health system, together with the support of grateful donors like Stacie Mathewson, we will continue to actively engage in outreach initiatives to raise awareness about mental health, reduce stigma and create a community that fosters healing and support.” Renown Health also earned Forbes' Best Healthcare Employer in Nevada for combatting burnout and ensuring well-being and safety of caregivers. Acerca de Renown Health Renown Health es la red de atención médica integrada de administración local y sin fines de lucro más grande de la región, que presta servicios a Nevada, Lake Tahoe y el noreste de California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Visite renown.org para obtener más información. About the University of Nevada, Reno School of Medicine The University of Nevada, Reno School of Medicine (UNR Med), Nevada’s first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Desde 1969, UNR Med ha capacitado a más de 3,900 estudiantes, residentes y becarios. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu.
-
Renown Health administrará vacunas contra la COVID-19 a personas mayores de 75 años
A partir del jueves, 14 de enero de 2021, con el fin de vacunar rápidamente a más residentes del condado de Washoe mayores de 75 años, Renown Health se complace en asociarse con el Distrito de Salud del Condado de Washoe para ayudar a distribuir los suministros inicialmente disponibles y limitados de vacunas contra la COVID-19. Las personas mayores de 75 años interesadas en unirse a la lista de espera para obtener una cita en la clínica de vacunación desde el automóvil de Renown deberán descargar MyChart de Renown, si no tienen una cuenta. Residents do not need to have a Renown Health provider to enroll. Residents will be notified through their MyChart account when appointments are available. The vaccine clinic is operating by appointment only. Debido a los recursos limitados y a la cantidad reducida de vacunas disponibles, el Programa de Vacunación contra la COVID-19 de Renown se concentrará inicialmente en vacunar a las personas mayores de 75 en el condado de Washoe. Según el gobernador Sisolak, y el plan de distribución de vacunas del estado, una vez que las personas mayores de 75 tengan la oportunidad de recibir la vacuna, el siguiente grupo prioritario de la población general es el de personas mayores de 70. Además, se notificará a los pacientes de Renown Health y a los miembros de Senior Care Plus/Hometown Health mayores de 75 mediante sus cuentas de MyChart de Renown a medida que haya citas disponibles. Once an appointment is confirmed, instructions are given on how to obtain the vaccine. “We remain steadfast in our determination to fight the good fight for our community. Being able to administer COVID19 vaccines is incredibly gratifying. The tragedy of COVID-19 is that the mortality rates, or the risk of dying, is highest in this generation,” said Tony Slonim, MD, DrPH, President & CEO of Renown Health. “We are pleased to be part of the solution, to bring hope and to make a genuine difference in the health and well-being of others.” Age increases risk for severe illness & hospitalization According to the CDC, the risk for severe illness with COVID-19 increases with age, with older adults at highest risk. El riesgo más alto de enfermarse de gravedad de COVID-19 lo tienen las personas mayores de 85 años. Severe illness means that a person with COVID-19 may require hospitalization, intensive care, or a ventilator to help them breathe, or they may even die. Solamente en el condado de Washoe, hay 29,034 personas mayores de 75 años, y Renown únicamente está recibiendo suministros limitados de la vacuna. Older adults are at greater risk of requiring hospitalization or dying if diagnosed with COVID-19. As you get older, your risk of being hospitalized for COVID-19 increases. Para las personas mayores de 75 años, el riesgo de hospitalización es entre ocho y treces veces mayor, con una tasa de mortalidad entre 220 y 630 veces más alta que los adultos más jóvenes. Compounding the risk for COVID-19 for older adults is a weakened immune system. “Because the immune system generally weakens with age, it’s important that older adults get a vaccine to help their bodies form a defense against COVID-19” says Derek Beenfeldt, MD, Chief Medical Officer for Hometown Health, the insurance division of Renown. “Please get vaccinated, unless you are sick or have significant allergic reactions to vaccines." You are advised not to receive the vaccine if: You are ill at the time of vaccination (fever, shortness of breath, vomiting, diarrhea or acute illness). se le ha diagnosticado COVID-19 en los últimos 14 días; recibió alguna otra vacuna en los últimos 14 días; You have a history of significant allergic reaction to this vaccine or any of its ingredients. Due to unprecedented demand, Renown is coordinating with local and state agencies to ensure every person has an opportunity to receive the vaccine over time. Downloading MyChart is not a guarantee of an appointment. Register for MyChart to be notified when you are eligible to make an appointment to receive the vaccine Renown Health will contact residents when it is time for them to receive their vaccine. Please do not contact a Renown doctor/health care provider at this time to schedule a vaccine appointment. Instead, all are encouraged to register for a Renown MyChart account if you have not already. The intricacies of vaccine administration Renown Health has been able to distribute and administer the COVID-19 vaccine to a record number of people in the shortest possible time. Gran parte de este éxito se debe al uso de un conveniente registro médico electrónico del paciente, llamado EPIC MyChart, que permite notificar a las personas que la vacuna está disponible, programar citas en línea, completar el formulario de consentimiento y tener documentación completa. In addition, the information automatically posts to Web IZ Nevada’s Statewide Immunization Information System. Stay Up-to-date on COVID-19 Renown Health is prepared to safely screen, diagnose and care for patients with respiratory illness, including COVID19. Para mantenerse actualizado sobre las comunicaciones sobre la distribución de Renown de la vacuna contra la COVID-19, las preguntas frecuentes y la evidencia científica detrás de la vacuna, visite https://renown.org/covid/ Únase al equipo de Renown Renown Health continúa comprometido con la contratación de personas para ocupar puestos clave en la organización para apoyar la salud y el bienestar de nuestra comunidad. Para unirse a la familia de Renown y luchar por la causa justa, postúlese en línea en https://careers.renown.org/ Acerca de Renown Health Renown Health es la red de atención médica integrada de administración y propiedad local sin fines de lucro más grande de la región, que brinda servicios a Nevada, Lake Tahoe y el noreste de California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned notfor-profit insurance company, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath, Neurosciences and Robotic Surgery. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®.
Leer más About Renown Health administrará vacunas contra la COVID-19 a personas mayores de 75 años
-
Renown vacuna contra la COVID-19 a 2,900 adultos mayores esta semana
Beginning today, Renown Health has partnered with the Washoe County Health District to help distribute the initially available, limited supplies of COVID-19 vaccines. Renown anunció hoy que esta semana puede vacunar de inmediato a 2,900 de los adultos de mayor edad en nuestra comunidad. Vea aquí fotos y un video de las primeras vacunaciones de adultos mayores que se realizaron hoy, así como fotos, videos y una entrevista sobre los eventos anteriores de vacunación de empleados de Renown. “We remain steadfast in our determination to fight the good fight for our community. Being able to administer COVID-19 vaccines to older adults in our community is incredibly gratifying for our team. The tragedy of COVID-19 is that the risk for severe illness with COVID-19 increases with age, with older adults at highest risk. Our oldest adults are also at greater risk of requiring hospitalization or dying if diagnosed with COVID19,” said Tony Slonim, MD, DrPH, President & CEO of Renown Health. “The Renown team is pleased to help, with support of and the vaccine provided by the Washoe County Health District, to be part of the solution, and to make a genuine difference in the health and well-being of others. Todos esperamos que la vacuna esté más ampliamente disponible para todos en las próximas semanas y meses”. Solamente en el condado de Washoe, más del 18 % de la población tiene más de 65 años, con 88,456 personas en ese grupo etario, y Renown únicamente está recibiendo suministros limitados de la vacuna La clínica de vacunación contra la COVID-19 de Renown funciona solo con cita, y funciona según la capacidad de Renown de obtener los suministros semanales inicialmente disponibles y limitados de la vacuna. Las personas mayores de 70 años interesadas en unirse a la lista de espera para obtener una cita en la clínica de vacunación contra la COVID-19 desde el automóvil de Renown deberán descargar MyChart de Renown, si actualmente no tienen una cuenta. Residents do not need to have a Renown Health provider and it is free to enroll. Residents will be notified through MyChart when more of the limited supply of vaccine is made available to Renown, and additional appointments are open for scheduling. Please do not contact a Renown doctor/health care provider at this time to schedule a vaccine appointment. Instead, all are encouraged to register for a Renown MyChart account if you have not already. Según la disponibilidad de la vacuna, Renown prevé ofrecer una siguiente ronda de citas a una muestra aleatoria de pacientes mayores de 70 tan pronto como el próximo lunes, 18 de enero al 12 mediodía. No additional appointments are available for this week. Se han programado y confirmado todas las 2,900 citas de esta semana. Se le recomienda no recibir la vacuna si: está enfermo al momento de la vacunación (fiebre, falta de aire, vómitos, diarrea o enfermedad aguda); se le ha diagnosticado COVID-19 en los últimos 14 días; recibió alguna otra vacuna en los últimos 14 días; You have a history of significant allergic reaction to this vaccine or any of its ingredients. Due to unprecedented demand, Renown is coordinating with local and state agencies to ensure every person has an opportunity to receive the vaccine over time. Downloading MyChart is not a guarantee of an appointment. The intricacies of vaccine administration Renown Health has been able to distribute and administer the COVID-19 vaccine to a record number of people in the shortest possible time. Much of this success is due to the use of a convenient patient electronic medical record, called EPIC MyChart, which allows people to be notified that the vaccine is available, schedule their appointments online, complete the consent form and have full documentation. In addition, the information automatically posts to Web IZ Nevada’s Statewide Immunization Information System. Stay Up-to-date on COVID-19 Renown Health is prepared to safely screen, diagnose and care for patients with respiratory illness, including COVID-19. Para mantenerse al día con las comunicaciones sobre la distribución de la vacuna contra la COVID-19 de parte de Renown, las preguntas frecuentes y la evidencia científica acerca de la vacuna, visite https://covid.renown.org. About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath and Neurosciences. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project® . Visite renown.org para obtener más información.
Leer más About Renown vacuna contra la COVID-19 a 2,900 adultos mayores esta semana
-
Renown Cardiologist Shares Insight on Warfarin
Renown Health's Dr. Christopher Rowan recently joined a distinguished panel of experts on the "Game Changers in Medicine" podcast to discuss the science behind the discovery of warfarin. Renown Health Cardiologist Dr. Christopher Rowan was just featured on an episode of Game Changers in Medicine, a groundbreaking medical history podcast from Dramatic Health about some of the world’s most significant medical discoveries. The episode, Warfarin: How a rat poison became one of the world's most widely prescribed drugs, dives into the fascinating history of Warfarin and its life-saving effects on humans. During the episode, Dr. Rowan, whose research focus is heart disease and atherosclerosis, is joined by experts Kevin Walters, Historian and Strategic Research Coordinator at the Wisconsin Alumni Research Foundation (WARF); and Ramya M. Rajagopalan, Ph.D. of the Institute for Practical Ethics at UC San Diego. Listen to the episode now or download it wherever you listen to podcasts. History of Warfarin Warfarin prevents blood clots from forming or expanding. The drug is especially important for individuals who have experienced a heart attack or stroke, or are at risk of experiencing either. However, the backstory of the drug is rather fascinating. Beginning in the 1920s, an unknown disease was killing cattle throughout the U.S. and Canada. Desesperado por encontrar una solución, un granjero condujo 200 millas hasta la University of Wisconsin con una vaca muerta, fardos de heno estropeado y una lata de leche con sangre sin coagular. El hombre se cruzó con un científico, cuyo equipo se propuso determinar el componente hemorrágico del heno estropeado, lo que dio como resultado una serie de descubrimientos médicos que revolucionarían la medicina. Tras aprender más sobre la warfarina y cómo la vitamina K podría revertir sus propiedades anticoagulantes, los médicos recetaron por primera vez la medicina para uso humano en 1954. Probablemente sea muy conocida por salvar al presidente Dwight D. Eisenhower después de que sufrió un ataque cardíaco en 1955. Today, Warfarin continues to saves millions of lives each year. “Before blood thinners like Warfarin, people would experience strokes, blood clots in their lungs, blood clots in their legs, blood clots in their hearts, along with countless other clotting disorders - these conditions likely cutting their lifespans short,” Dr. Rowan said during the podcast. “Warfarin revolutionized the treatment of patients who suffer from heart attacks and strokes, helping them to live normal and healthy lives. The drug changed medicine forever and helped make incredible innovations such as mechanical heart valves a reality.” Interview Opportunity Dr. Rowan is available for interviews to discuss the importance of this unique medical discovery and the positive impact it has on many of the patients he treats every day. Envíe un correo electrónico a news@renown.org o llame al 775-691- 7308 para coordinar una entrevista. Acerca de Renown Health Renown Health es la red de atención médica integrada de propiedad y administración local y sin fines de lucro más grande de la región, que presta servicios en Nevada, Lake Tahoe y el noreste de California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath, Neurosciences and Robotic Surgery. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project® . Visite renown.org para obtener más información. About Dramatic Health Dramatic Health, a national healthcare video company, is the producer of the six-part podcast series Game Changers in Medicine. The series premiered in July with an episode about Vitamin K and an enterprising Boston house doctor. The August episode showcased the creation of a smallpox vaccine and its parallels to today's urgent search for a COVID-19 vaccine. Game Changers in Medicine se clasificó en el puesto 27 de los podcasts de Apple en la categoría “Ciencias de la vida en los Estados Unidos” de acuerdo con Chartable al 21 de agosto de 2020. Los dos episodios, un resumen de la serie y material adicional sobre la serie de podcasts están disponibles en www.gamechangersinmedicine.com y se puede acceder a estos materiales desde la plataforma que utilice para escuchar podcasts.
Leer más About Renown Cardiologist Shares Insight on Warfarin
-
Awareness Saves Lives: Renown se viste de azul en el Mes de la Concientización sobre el Cáncer Colorrectal
After a year of possibly delayed colorectal cancer screenings due to theCOVID-19 pandemic, it’s more important than ever to raise awareness for colorectal cancer. March is National Colorectal Cancer Awareness Month- a time to raise awareness for colorectal cancer and the importance of routine, life-saving screenings. Renown invites the community to join the organization in helping put an end to the preventable disease. Blue is the designated color to bring awareness to colorectal cancer and those impacted by it. The iconic “LOVE” sculpture at the main entrance of Renown Regional Medical Center located at 1155 Mill Street in Reno, Nev. will shine brightly in blue each evening in March, serving as a visual reminder to passersby to schedule a colorectal screening. La Colorectal Cancer Alliance estima que se presentarán 149,500 nuevos casos de cáncer de colon solo en 2021. While colorectal cancer may be the second deadliest cancer in men and women combined, it is also one of the most preventable cancers with screenings. “Unfortunately, due to the COVID-19 pandemic, there’s been a decline in colorectal screenings nationwide,” said Tony Slonim, MD, DrPH, President and CEO of Renown Health. “We know early detection is key in preventing the spread of any cancer, and with regular screenings, we know colorectal cancer is easily detectable and treatable. As a cancer survivor, I know how important it is to get back on track with regular screenings and preventive care. Making your health a priority now will help you experience a healthier and brighter tomorrow.” “We invite the community to join us at Renown in spreading awareness about colorectal cancer and its prevention,” said Susan Cox, director of cancer services at the Renown Institute for Cancer. “It takes all of us to put an end to colorectal cancer. If you’re up to date on your screenings, remind a loved one to schedule their next screening--as your reminder may have the power to save their life.” “Colorectal cancer usually forms from precancerous polyps, or abnormal growths, in the colon or rectum, which can become malignant without presenting any symptoms. Screening tests like stool tests, colonoscopies, and others can detect these precancerous polyps, so they can be removed by a physician before turning into cancer. Screening tests can also find colorectal cancer early, resulting in better treatment outcomes,” says Christos Galanopoulos, M.D., MBA, oncologic surgeon, VP Renown Health & Chair of Surgery for Renown Health. El Dr. Galanopoulos agrega: “la mayoría de las personas comienzan a realizarse exámenes de detección del cáncer colorrectal después de cumplir los 50 años. However, some individuals may begin screenings earlier if they have an increased risk of colorectal cancer, such as a family history with the disease. Regardless of one’s personal or family history of colorectal cancer, it’s important to talk to your doctor about the right time to begin your screenings.” Max J. Coppes, MD, Cancer Center Director, Renown Institute for Cancer adds, “While routine screenings are the only way to determine colorectal health, some healthy habits may reduce your risk for colorectal cancer. Estos factores incluyen mantener un peso saludable, mantenerse físicamente activo, seguir una dieta rica en frutas frescas, verduras y granos integrales, limitar el consumo de alcohol y no fumar”. El Dr. Coppes explica que “1 de cada 500 estadounidenses dará positivo para el síndrome de Lynch, una afección genética que aumenta el riesgo de padecer cáncer de colon, cáncer de endometrio y otros tipos de cáncer. It is also known as hereditary nonpolyposis colorectal cancer. People with Lynch Syndrome are also susceptible to colon polyps at a younger age. The Healthy Nevada Project research team is looking at the occurrence of important inherited genetic variants in our population that increase the risk of certain diseases. These include Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome and Lynch Syndrome.” To enroll in The Healthy Nevada Project, a clinical study (saliva test) offering the opportunity to learn about your ancestry, diet insights and genetic risks linked to heart disease and certain cancers, including prevention strategies, at no cost, enroll here. For a limited time, Nevada residents may request a free DNA test kit that will be shipped to your home. Renown experts encourage every adult to talk to their doctor about their colorectal cancer risk and screening options. Aquellos que buscan programar un examen de detección o una visita de atención con un proveedor de atención primaria de Renown pueden a llamarnos al 775-691-7308 o a visitar nuestro sitio web para obtener más información. About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath and Neurosciences. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®.
-
Use Caution: Mixing Over-the-Counter Medications Can Be Harmful
When you’re too sick to go to work but not sick enough for a doctor’s visit, over-the-counter medicines are a welcome relief to help alleviate that fever, runny nose or allergies. But because those medicines aren’t signed off on or managed by your doctor and pharmacist, you must be especially mindful of what you put into your body. Whenever you pop a pill, you want to ensure you’re taking the correct dosage, waiting the right amount of time before taking another dose and not mixing certain medicines. Too Much Tylenol/Acetaminophen Tylenol — or acetaminophen — is a popular pain reliever for many, but too much can be bad for your liver. “Our bodies have a finite ability to metabolize Tylenol,” says Andy Wright, clinical pharmacist at Renown Rehabilitation Hospital. “When too much builds up in the liver, it becomes toxic. In patients with medical conditions like cirrhosis of the liver or hepatitis, this could be disastrous.” Remember, acetaminophen is in more than just Tylenol and generic pain relievers. You may also see acetaminophen in flu, cold and cough medicines, like Nyquil, and some prescription medications including Norco and Percocet. Keep a list of the medications you take, and limit daily acetaminophen use to 3,000 mg per day. When you’re scanning medicine bottle contents, remember acetaminophen is also referred to as APAP, AC, acetam or paracetamol. Mixing Painkillers When you’re dealing with pain and not getting any relief, taking a different medication may seem like the easy solution. Maybe you take some Aleve — a form of naproxen — for a headache, but it isn’t working, so you switch to Motrin, an over-the-counter form of ibuprofen. Not a smart idea. Ibuprofen and naproxen along with aspirin are known as nonsteroidal anti-inflammatory drugs (NSAIDS). Because these medicines work in similar ways, they should never be combined or used in larger doses or more frequently than directed. Otherwise your risk of side effects can increase, which range from mild nausea to severe gastrointestinal bleeding. It’s also important to consider your family history when taking NSAIDs because, “recent studies have shown NSAIDs may have greater cardiovascular risks for people taking blood thinners or those with hypertension,” explains Andy. “A good example is ibuprofen: It has a relatively low gastrointestinal bleed risk while it has a moderate to high cardiovascular risk. The opposite is true for naproxen.” Rather than experimenting with multiple medicines, figure out which drug works best for you. You may find muscle soreness improves with aspirin, whereas when a headache hits, naproxen is best. Keep in mind that these medications aren’t always best for everyone in the family. “Aspirin in children and teens is not recommended unless under the supervision of a doctor,” Andy says. And pregnant and lactating women should generally avoid NSAIDS due to risk of birth defects and bleeding. “In both of these cases, acetaminophen or Tylenol are preferred but only if approved by an OB/GYN.” Fighting Allergies Over-the-counter antihistamines like Claritin, Zyrtec and Allegra have made fighting itchy eyes and runny noses a little easier. But these daily medicines — when taken inappropriately or in the wrong combinations — can also have an adverse effect. Similar to acetaminophen, you need to watch for antihistamines in other products. Sleep aids — like Tylenol PM and Unisom — commonly use an antihistamine known as diphenhydramine, which may increase your risk of overdose. “Combining antihistamines, or overdosing, can cause many adverse effects including dry mouth, blurred vision — even arrhythmias,” Andy says. “Only take these medications on their own.” If you’re still struggling with symptoms, you can talk to your doctor about adding an over-the-counter nasal steroid. Andy confirms the importance of closely following the directions listed on antihistamine (and all medicine) bottles. He has seen extended release nasal decongestants cause significant arrhythmias requiring medical care after a patient took the medicine with warm fluids. “The decongestant in question is designed to slowly release, but it can dissolve suddenly in the presence of warm liquids like coffee,” Andy explains. “This can cause the pill to deliver 12 to 24 hours of medication all at once.” Taking an Antidiarrheal with Calcium Calcium supplements and antidiarrheal medicines are another harmful combination. Calcium firms up your stool, but if taken with an antidiarrheal, can cause severe constipation. If you need to take an antidiarrheal, take a break from your calcium for a few days until you’re back to normal. Another consideration when taking calcium supplements or calcium-based antacids is gas. “I’ve had several patients report cases of excessive gas using Tums or calcium carbonate-based supplements.” Andy suggests instead “trying Maalox or Mylanta for indigestion and Citracal as a supplement.” Talk with Your Doctor or Pharmacist About Your Medications If over-the-counter drugs aren’t providing the relief you need, it’s time to see your doctor. And remember, for your safety it is important to keep your doctor and pharmacist up-to-date with any medications — prescribed or over-the-counter — that you are taking.
Read More About Use Caution: Mixing Over-the-Counter Medications Can Be Harmful
-
Enfermedad hepática no alcohólica y genética: ¿Existe alguna relación?
What exactly is the relationship between genetics and disease? Powered by Renown Health, the Healthy Nevada Project is one of the most visible genomic studies in the United States. They are recruiting participants here in northern Nevada to understand the relationship between genetics and nonalcoholic liver disease. Joseph Grzymski, Principal Investigator at the Healthy Nevada Project and Chief Scientific Officer at Renown Health, shares why this study is so important and who should take part. Many people are aware that heavy drinking can lead to liver disease. Yet they are unaware that other types of liver disease are not caused by alcohol consumption. These types of liver disease are more difficult to diagnose but are equally dangerous. What is NASH? A build-up of fat causes nonalcoholic Fatty Liver Disease (NAFLD) in the liver. The most dangerous form is called Nonalcoholic Steatohepatitis (NASH). It causes inflammation and damages liver cells, leading to fibrosis, scarring of the liver, and decreased liver function. If NASH goes untreated, irreversible liver damage can occur, leading to cirrhosis, cancer, or liver failure. These conditions can be fatal. What’s most concerning about NASH is that the symptoms don’t typically cause pain and aren’t noticeable. The good news is that a new local study is raising awareness about this disease by recruiting at-risk people for NASH. Am I at risk for developing NASH? The following factors put you at risk: Obesity Type 2 diabetes Metabolic syndrome High blood lipids, such as cholesterol and triglycerides Does having a family member with nonalcoholic liver disease increase my risk? We do not know a lot about inheriting NASH, although a lot risk factors run in families. One goal of this study is to better understand the genetic component of NASH. There are certainly other risks too, such as environmental and behavioral risk factors. However, we don’t yet have a good grasp on how these impact NASH risk. How is NASH diagnosed? Diagnosis is traditionally done with either a liver ultrasound or biopsy. However, both procedures are expensive and the invasive biopsy has risks. Therefore doctors often use risk factors or less invasive blood tests for diagnosis. This NASH study will include a new blood test called the enhanced liver function (ELF) test. Doctors and researchers have data suggesting that the ELF test is a better diagnostic test for NASH risk. Conducting this cutting-edge test with study participants allows them to share results with their doctors to ensure the best care. What can I do to reduce my NASH risk? Limiting exposure to the risk factors of NASH often lowers risk. Eating a healthy diet, maintaining a recommended weight and exercising regularly can proactively lower your risk.
Read More About Nonalcoholic Liver Disease and Genetics: Is There a Link?
-
La detección temprana es clave para sobrevivir al cáncer colorrectal
Colorectal cancer is the number two cancer killer in Nevada, only second to lung cancer, yet it is also one of the most preventable. Still, in 2020, 20.7% of Nevadans said they had never been screened for this deadly disease, according to the Nevada Cancer Coalition. At the start of the COVID-19 pandemic, unfortunately many healthcare services were halted, including colorectal cancer screenings. Those delays in screenings can lead to delays in diagnoses of colorectal cancer, resulting in poorer outcomes. Per the American Cancer Society, if colorectal cancer can be found early the relative 5-year survival rate is approximately 90%. Screening is key, and it is important to engage in preventative care. Even if you have no personal or family history of colorectal cancer, ask your doctor about colorectal risk factors and when to start screening, and if you’re up to date on your screenings, talk to loved ones and make sure they are too. According to the American Cancer Society, most colorectal cancer cases are found in those without a family history. This month let us help raise awareness for colorectal cancer and the importance of routine, life-saving screenings. To learn more, we spoke to Renown Health oncology nurse Christina Alsop, APRN. What is Colorectal Cancer Colorectal cancer is a disease in which the cells in the colon or rectum grow out of control. It usually forms from precancerous polyps, or abnormal growths, in the colon or rectum, which can become malignant without presenting any symptoms. How do Screenings Work Screening tests like stool tests, colonoscopies and others can detect these precancerous polyps, so they can be removed by a physician before turning into cancer. Screening tests can also find colorectal cancer early, resulting in better treatment outcomes. As of 2021, the U.S. Preventative Services Task Force recommends adults begin colorectal cancer screenings beginning at age 45, through 75. Screening methods include a blood stool test, which needs to take place every year or a colonoscopy, which takes place every 5-10 years. Healthy Habits Can Help Stave Off Risk Routine screenings are the only way to determine colorectal health, yet some healthy habits may reduce your risk for colorectal cancer. These factors include maintaining a healthy weight, being physically active, eating a diet rich in fresh fruits, vegetables and whole grains, limiting alcohol intake and not smoking.
Read More About Early Detection is Key to Surviving Colorectal Cancer
-
Update: La creciente demanda del programa de vacunación contra la COVID-19 de Renown por parte de los mayores de 70 años excede los suministros limitados
A fin de vacunar rápidamente a más residentes del condado de Washoe mayores de 70 años, Renown Health se ha asociado con el Distrito de Salud del Condado de Washoe para ayudar a distribuir los suministros limitados inicialmente disponibles de vacunas contra la COVID-19. Due to the unprecedented demand of local residents, Renown now has a full “waiting list” for those interested in the COVID-19 vaccine, and will be working through the list to offer appointments as they become available. Renown continues to vaccinate physicians and its essential workforce for COVID-19, and to provide nasal swab testing for those with a lab order from their provider, for COVID-19 symptoms. Además, Renown ha ampliado su apoyo al Distrito de Salud del Condado de Washoe para satisfacer las necesidades de las personas mayores de 70 años que ahora son elegibles para recibir una vacuna contra la COVID-19. Durante el pasado fin de semana, más de 3,000 de los residentes más longevos del condado de Washoe pudieron obtener una cita y recibir su primera dosis de la vacuna contra la COVID-19 en la clínica de vacunación contra la COVID-19 al paso de Renown. Please see b-roll, photos and fly-over footage here. Eligibility is one thing; availability is another. El condado le proporcionó a Renown otras 3,000 vacunas para administrar este fin de semana. Renown publicó 3,000 citas disponibles para los inscritos en la lista de espera electrónica de MyChart y el 100 % de las citas se reservaron en una hora. “We want to help the Health District, and we are working to vaccinate as many people as possible, given our limited staffing, volunteers, space and vaccine,” says Melodie Osborn, RN, Chief Nursing & Quality Officer for Health Services. “We are glad to step in and help; and our goal is to always provide an exceptional vaccine experience. Our team and our systems are definitely feeling the pressure as we see unprecedented demand for this vaccine. We ask the public to be patient with us, and to help support us in this important work.” Scheduling limited Both the Pfizer and Moderna COVID-19 vaccines require two doses, the second administered three to four weeks after the first. Renown is working to be sure those who receive their first dose also obtain their second dose in a timely manner. Esto incluye a 7,000 médicos y trabajadores de la atención médica, y ahora incluirá a los adultos mayores vacunados con la primera dosis. La complejidad de los requisitos de dosificación de las vacunas sigue reduciendo el número de vacunas y citas disponibles. Los sistemas telefónicos y de MyChart de Renown se ven afectados por la demanda El jueves pasado, cuando Renown anunció que los mayores de 75 años podían inscribirse en la lista de espera al descargar Renown EPIC MyChart, se conectaron tantas personas que el sistema se vio sobrecargado para dar cabida a la demanda adicional. Renown ahora ha duplicado la capacidad del sistema EPIC MyChart para asegurarse de que todo fluya sin problemas. Renown Health ha sido capaz de distribuir y administrar la vacuna contra la COVID-19 a un número récord de personas en el menor tiempo posible. Gran parte de este éxito se debe al uso de EPIC MyChart, un conveniente registro médico electrónico del paciente que permite a las personas programar sus citas en línea, completar el formulario de consentimiento y tener documentación completa para el futuro. In addition, the information automatically posts to Web IZ Nevada’s Statewide Immunization Information System. Also last Thursday, older adults without cell phones, computers or someone to assist them, called Renown’s customer service phone line for assistance. So many people called the phone line that it crashed. Service has been restored, but is limited, due to the hundreds of calls coming in daily that are answered by a limited number of trained staff members. Medically-trained vaccinators needed To expand capacity and to assist in the administration of vaccines, Renown Health is seeking those who are medically trained to give vaccinations to join their team on a seasonal basis to support the health and well-being of our community. Las personas capacitadas e interesadas pueden presentar su solicitud en línea en https://careers.renown.org/ Regístrese en MyChart, que le pondrá en la lista de espera para recibir la vacuna Renown anima a cualquier persona interesada en ingresar en la lista de espera a que obtenga una cuenta de Renown MyChart si aún no lo ha hecho. Al hacerlo, se le añadirá a la lista de personas mayores de 70 años que esperan una cita para recibir la vacuna contra la COVID-19. Please do not contact a Renown doctor/health care provider at this time to schedule a vaccine appointment. Due to unprecedented demand, Renown is coordinating with local and state agencies to ensure every person has an opportunity to receive the vaccine over time. You are advised not to receive the vaccine if: está enfermo al momento de la vacunación (fiebre, falta de aire, vómitos, diarrea o enfermedad aguda); se le ha diagnosticado COVID-19 en los últimos 14 días; recibió alguna otra vacuna en los últimos 14 días; tiene antecedentes de reacción alérgica considerable a esta vacuna o a cualquiera de sus componentes. Apoye a al equipo de Renown Renown Health, una organización benéfica sin fines de lucro, agradece profundamente el apoyo de la comunidad en estos momentos sin precedentes. Si desea donar para ayudar a Renown y que Renown ayude nuestra comunidad, visite https://www.renown.org/donations-covid19/. About Renown Health Renown Health is the region’s largest, locally owned and governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Renown’s institute model addresses social determinants of health and includes: Child Health, Behavioral Health & Addiction, Healthy Aging and Health Innovation. Clinical institutes include: Cancer, Heart and Vascular Heath, Neurosciences and Robotic Surgery. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®. Visite renown.org para obtener más información.
-
Population Genetic Screening Show to Efficiently Identify Increased Risk for Inherited Disease
El enfoque basado en la comunidad del Healthy Nevada Project revela que hasta un 90 % de los riesgos de padecer afecciones genéticas de Nivel 1 de los CDC no se detecta cuando se usan pautas de atención clínica. In a new study published today in the journal Nature Medicine, researchers behind the Healthy Nevada Project® suggest that community-based genetic screening has the potential to efficiently identify individuals who may be at increased risk for three common inherited genetic conditions known to cause several forms of cancer and increased risk for heart disease or stroke. En 2018, el Healthy Nevada Project® (el mayor estudio de salud poblacional basado en la comunidad que combina datos genéticos, clínicos, ambientales y sociales) comenzó a notificarles a los participantes del estudio que habían dado su consentimiento sobre ciertas variantes genéticas que los predisponían a padecer las afecciones genéticas de Nivel 1 de los Centros para el Control y la Prevención de Enfermedades (Centers for Disease Control and Prevention, CDC). The study focused on identifying carriers of these conditions, which include Hereditary Breast and Ovarian Cancer, Lynch Syndrome, and Familial Hypercholesterolemia, because they are the most common conditions and early detection and treatment could significantly lower morbidity and mortality. Los resultados iniciales de casi 27,000 participantes del estudio mostraron que el 90 % de los portadores de las afecciones genéticas de Nivel 1 de los CDC no había sido previamente identificado en un entorno clínico. The authors conclude that population genetic screening would identify at-risk carriers not identified during routine care. “Our first goal was to deliver actionable health data back to the participants of the study and understand whether or not broad population screening of CDC Tier 1 genomic conditions was a practical tool to identify at-risk individuals,” explained Joseph Grzymski, Ph.D., the principal investigator of the Healthy Nevada Project®, a research professor at the Desert Research Institute (DRI), chief scientific officer for Renown Health and lead author of the study. “Now, two years into doing that, it is clear that the clinical guidelines for detecting risk in individuals are too narrow and miss too many at risk individuals.” Del grupo de 26,906 participantes del Healthy Nevada Project® que el equipo de investigación de Grzymski estudió, 358 (el 1.33 %) eran portadores de afecciones de Nivel 1 de los CDC. Sin embargo, solo el 25 % de esas personas cumplían las pautas clínicas para realizarse exámenes de detección genética. Además, más del 20 % de los portadores ya tenía un diagnóstico de enfermedad relacionada con la afección genética subyacente. “We’re at a point now where it’s possible to do clinical-grade genetic screening at population-scale,” added James Lu, M.D. Ph.D., co-founder and chief scientific officer of Helix and senior co-author of the study. “What this study demonstrates is the potential impact of doing so. By making genetic screening available more broadly, we can help the millions of Americans who are unaware that they are living at increased risk for highly actionable, genetic conditions take action.” En particular, el estudio descubrió que de los 273 participantes que eran portadores de las afecciones genéticas de Nivel 1 de los CDC y que tenían información de registros clínicos, solo 22 personas mostraron sospechas previas de tener estas afecciones genéticas subyacentes. “For the first time, we are providing information at the individual level so study participants can make lifesaving changes to reduce their risk based on their genetics,” said Anthony Slonim, M.D., Dr.PH., FACHE, president and CEO of Renown Health and co-director of the Project® study. “We’re conducting research on the community level to develop leading-edge research on health determinants for entire neighborhoods, states and eventually, the country. Returning these results allows us to understand the prevalence of genetically programmed diseases and illnesses that we have here in Nevada and ensure we are providing the best prevention and care plans. For the individual, the return of results can be life changing.” According to the CDC, early detection and intervention of the Tier 1 genetic conditions could have a meaningful potential for clinical action ability and a positive impact on public health. El Healthy Nevada Project®, que se lanzó en 2016, ofrece pruebas genéticas gratuitas a todos los residentes de Nevada, mayores de 18 años, interesados en obtener más información sobre su salud y perfil genético. Con más de 50,000 participantes del estudio inscritos en cuatro años, el Healthy Nevada Project® se ha convertido en el estudio genético de más rápida inscripción del mundo. For more about the Healthy Nevada Project® please visit healthynv.org Renown Institute for Health Innovation is a collaboration between Renown Health – a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute – a recognized world leader in investigating the effects of natural and human induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at Healthynv.org. Helix is the leading population genomics company operating at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+Ⓡ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research. In response to the COVID-19 public health crisis, Helix has launched a sensitive and scalable end-to-end COVID-19 test system to meet the needs of health systems, employers, governments, and other organizations across the country. Obtenga más información en www.helix.com.